948571-52-6

Basic information

• Product Name: tert-butyl 2-(4-hydroxy-2-methoxyphenyl)acetate
• Synonyms: tert-butyl 2-(4-hydroxy-2-methoxyphenyl)acetate
• CAS NO: 948571-52-6
• Molecular Weight: 238.284
• Mol File: 948571-52-6.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: tert-butyl 2-(4-hydroxy-2-methoxyphenyl)acetate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 2-(4-hydroxy-2-methoxyphenyl)acetate(948571-52-6)
• EPA Substance Registry System: tert-butyl 2-(4-hydroxy-2-methoxyphenyl)acetate(948571-52-6)

Safety Data

• Hazardous Substances Data: 948571-52-6(Hazardous Substances Data)

Upstream product

• 863310-59-2 [4-(benzyloxy)-2-methoxyphenyl]acetic acid 
• 18278-34-7 4-hydroxy-2-methoxybenzaldehyde 
• 58026-14-5 4-(benzyloxy)-2-methoxybenzaldehyde 
• 883985-70-4 2-(4-benzyloxy-2-methoxyphenyl)acetonitrile 
• 948571-54-8 tert-butyl [4-(benzyloxy)-2-methoxyphenyl]acetate 

Downstream Products

• 948571-12-8 N-(1,3-dimethyl-1H-pyrazol-4-yl)-2-[2-methoxy-4-(7-methoxyquinolin-4-yloxy)phenyl]acetamide 
• 952059-80-2 2-[2-methoxy-4-(6-methoxy-1,5-naphthyridin-4-yloxy)phenyl]acetic acid 
• 952059-55-1 2-[2-methoxy-4-(1,7-naphthyridin-4-yloxy)phenyl]acetic acid 

Relevant articles and documents

NAPHTHYRIDINE DERIVATIVES

The invention concerns naphthyridine derivatives of Formula (Ia) or (Ib) or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, G1, G2, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders or disease states associated with angiogenesis and/or vascular permeability.

QUINOLINE DERIVATIVES

The invention concerns quinoline derivatives of Formula (I): or a pharmaceutically-acceptable salt thereof, wherein each of X1, p, R1, q, R2, R3, R4, R5, Ring A, r and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.